Point-of-care Tests in Development Universal Biosensors has a range of point-of-care blood tests in development including a C-reactive protein test which may be used to assist in the diagnosis and management of inflammatory conditions and a prothrombin time test which may be used for monitoring the therapeutic range of the anticoagulant, warfarin. Universal Biosensors provides research and development services in the development of a blood glucose test. Universal Biosensors intends to extend its range of point-of-care tests and develop further improvements to its existing tests, including an expanded range of immunoassay tests. The diagnostic blood tests are designed for use by patients and healthcare professionals in a number of point-of-care settings including doctors surgeries, emergency rooms, and health clinics or at a patient’s home. Point-of-care tests produce immediately actionable healthcare data to enable treatment to be reviewed and adjusted to suit each patient’s condition at the point-of-care. Point-of- care tests have the potential to reduce overall costs to the healthcare system.